Shivangi Harankhedkar: Gene Therapy and CRISPR Advances in Hemoglobinopathies
Shivangi Harankhedkar, Head Department of Molecular Diagnostics and Research IMS and SUM Hospital at Siksha ‘O’ Anusandhan University, shared a post on LinkedIn:
“It was a privilege to chair the session ‘Gene Therapy and CRISPR-Based Curative Approaches in Hemoglobinopathies’, delivered by Dr Debojyoti Chakraborty, Molecular Scientist, RNA Biology Lab at CSIR – Institute of Genomics and Integrative Biology, at the CME ‘Hemoglobinopathies 2026: Challenges, Care, Cure’, organised at AlIMS Bhubaneswar on the occasion of World Sickle Cell Day.
The session provided an insightful overview of how advances in gene addition and CRISPR-based genome editing are transforming the treatment landscape of sickle cell disease-from lifelong disease control towards the possibility of durable, potentially curative therapy.
The development of BIRSA-101, India’s first indigenous CRISPR-based gene therapy for sickle cell disease, represents a landmark initiative towards making advanced genomic therapies more relevant and accessible within our own healthcare setting.
India and particularly Odisha, with its significant burden of sickle cell disease-looks forward with great hope to its clinical development and successful translation into an affordable treatment for our patients.
Grateful to the organisers, happy that I could attend this encouraging and meaningful academic programme.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome
-
Nov 17, 2026, 13:37Abdlemewla Ibrahim: Prasugrel vs Ticagrelor in ACS Patients Undergoing PCI
-
Nov 17, 2026, 13:30Stacy E. Croteau: Oral and Dental Care in Pediatric Patients With Bleeding Disorders
-
Nov 17, 2026, 13:19Efe Saglam: Cannabis Use and Cardiac Conduction
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop